Recent trends in opioid prescriptions in Korea from 2002 to 2015 based on the Korean NHIS-NSC cohort
1
조회
0
다운로드
8
인용
0
참고문헌
키워드
초록
OBJECTIVES: Opioids are prescribed to treat moderate to severe pain. We investigated recent trends in opioid (morphine, oxycodone, fentanyl, and hydromorphone) prescriptions using data from the Korean National Health Insurance Service-National Sample Cohort between 2002 and 2015. METHODS: The morphine milligram equivalent (MME) was calculated to standardize the relative potency of opioids. The number (cases) or amount (MME) of annual opioid prescriptions per 10,000 registrants was computed to analyze trends in opioid prescriptions after age standardization. Joinpoint regression analysis was conducted to calculate the annual percentage change and average annual percentage change (AAPC). RESULTS: The number (cases) of prescriptions per 10,000 registrants increased from 0.07 in 2002 to 41.23 in 2015 (AAPC, 76.0%; 95% confidence interval [CI], 61.6 to 91.7). The MME per 10,000 registrants increased from 15.06 in 2002 to 40,727.80 in 2015 (AAPC, 103.0%; 95% CI, 78.2 to 131.3). The highest AAPC of prescriptions and MME per 10,000 registrants were observed in the elderly (60-69 years) and in patients treated at general hospitals. Fentanyl prescriptions increased most rapidly among the 4 opioids. CONCLUSIONS: Consumption of opioids greatly increased in Korea over the 14-year study period.
Abstract
OBJECTIVES: Opioids are prescribed to treat moderate to severe pain. We investigated recent trends in opioid (morphine, oxycodone, fentanyl, and hydromorphone) prescriptions using data from the Korean National Health Insurance Service-National Sample Cohort between 2002 and 2015. METHODS: The morphine milligram equivalent (MME) was calculated to standardize the relative potency of opioids. The number (cases) or amount (MME) of annual opioid prescriptions per 10,000 registrants was computed to analyze trends in opioid prescriptions after age standardization. Joinpoint regression analysis was conducted to calculate the annual percentage change and average annual percentage change (AAPC). RESULTS: The number (cases) of prescriptions per 10,000 registrants increased from 0.07 in 2002 to 41.23 in 2015 (AAPC, 76.0%; 95% confidence interval [CI], 61.6 to 91.7). The MME per 10,000 registrants increased from 15.06 in 2002 to 40,727.80 in 2015 (AAPC, 103.0%; 95% CI, 78.2 to 131.3). The highest AAPC of prescriptions and MME per 10,000 registrants were observed in the elderly (60-69 years) and in patients treated at general hospitals. Fentanyl prescriptions increased most rapidly among the 4 opioids. CONCLUSIONS: Consumption of opioids greatly increased in Korea over the 14-year study period.
참고문헌 (32)
- Treede RD, "The International Association for the Study of Pain definition of pain : as valid in 2018 as in 1979, but in need of regularly updated footnotes", Pain Rep, 3, pp.e643~ (2018)
- Wiffen PJ, "Opioids for cancer pain-an overview of Cochrane reviews", Cochrane Database Syst Rev, 7, pp.CD012592~ (2017)
- van den Beuken-van Everdingen MH, "Update on prevalence of pain in patients with cancer : systematic review and meta-analysis", J Pain Symptom Manage, 51, pp.1070~1090 (2016)
- Ho KY, "Inadequate treatment practices for pain relief and adverse event management in cancer patients across 10 countries", regions in Asia : a call for greater efforts to improve standards for patient care, 2018, pp.14, 159~166
- Johannes CB, "The prevalence of chronic pain in United States adults : results of an Internet-based survey", J Pain, 11, pp.1230~1239 (2010)
- Breivik H, "Survey of chronic pain in Europe : prevalence, impact on daily life, and treatment", Eur J Pain, 10, pp.287~333 (2006)
- Ventafridda V, "WHO guidelines for the use of analgesics in cancer pain", Int J Tissue React, 7, pp.93~96 (1985)
- Swarm RA, "Adult cancer pain, version 3. 2019, NCCN clinical practice guidelines in oncology", J Natl Compr Canc Netw, 17, pp.977~1007 (2019)
- Duthey B, "Adequacy of opioid analgesic consumption at country, global, and regional levels in 2010, its relationship with development level, and changes compared with 2006", J Pain Symptom Manage, 47, pp.283~297 (2014)
- Bosetti C, "Trends in the consumption of opioids for the treatment of severe pain in Europe, 1990-2016", Eur J Pain, 23, pp.697~707 (2019)
- Kang KH, "Trends in major opioid analgesic consumption in Taiwan, 2002-2014", J Formos Med Assoc, 116, pp.529~535 (2017)
- Zin CS, "Ten years of strong opioid analgesics consumption in Malaysia and other Southeast Asian countries", J Pharm Bioallied Sci, 12(Suppl 2), pp.S846~S851 (2020)
- Lee J, "Cohort profile : the National Health Insurance Service-National Sample Cohort(NHIS-NSC), South Korea", Int J Epidemiol, 46, pp.e15~ (2017)
- "About CDC’s opioid prescribing guideline"[URL]
- "Joinpoint trend analysis software"[URL]
- Zin CS, "Changes in trends and pattern of strong opioid prescribing in primary care", Eur J Pain, 18, pp.1343~1351 (2014)
- "Cancer pain relief: with a guide to opioid availability" (1996)[URL]
- Hamunen K, "Trends in opioid consumption in the Nordic countries 2002-2006", Eur J Pain, 13, pp.954~962 (2009)
- Kalkman GA, "Trends in use and misuse of opioids in the Netherlands : a retrospective, multi-source database study", Lancet Public Health, 4, pp.e498~e505 (2019)
- Hider-Mlynarz K, "Trends in analgesic consumption in France over the last 10 years and comparison of patterns across Europe", Br J Clin Pharmacol, 84, pp.1324~1334 (2018)
- Ruscitto A, "Changes in opioid and other analgesic use 1995-2010 : repeated cross-sectional analysis of dispensed prescribing for a large geographical population in Scotland", Eur J Pain, 19, pp.59~66 (2015)
- Nissen SK, "Trends of opioid utilisation in Denmark : a nationwide study", Drugs Real World Outcomes, 6, pp.155~164 (2019)
- Oh TK, "Trends in chronic opioid use and association with five-year survival in South Korea : a population-based cohort study", Br J Anaesth, 123, pp.655~663 (2019)
- Weesie YM, "Use of opioids increases with age in older adults : an observational study(2005-2017)", Front Pharmacol, 11, pp.648~ (2020)
- Zin CS, "Trends and patterns of analgesic prescribing in Malaysian public hospitals from 2010 to 2016 : tramadol predominately used", J Pain Res, 11, pp.1959~1966 (2018)
- Castañeda AM, "Addressing opioid-related chemical coping in long-term opioid therapy for chronic noncancer pain : a multicenter, observational, cross-sectional study", J Clin Med, 7, pp.354~ (2018)
- Choi HY, "Market analysis of narcotic analgesics in Korea using HIRA claims data", J Korean Acad Manag Care Pharm, 4, pp.31~37 (2015)
- 홍세리, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2018", Cancer Research and Treatment, 53(2), pp.301~315 (2021), 대한암학회[DOI]
- 경민호, "국내 호스피스·완화의료 현황 및 활성화 방안 - 호스피스·완화의료 기관 조사를 바탕으로", Journal of Hospice and Palliative Care, 13(3), pp.143~152 (2010), 한국호스피스완화의료학회
- Cho NR, "Trends in opioid prescribing practices in South Korea, 2009-2019: are we safe from an opioid epidemic?", PLoS One, 16, pp.e0250972~ (2021)
- Wilson N, "Drug and opioid-involved overdose deaths-United States, 2017-2018", MMWR Morb Mortal Wkly Rep, 69, pp.290~297 (2020)
- Häuser W, "Is Europe also facing an opioid crisis? – a survey of European Pain Federation chapters", Eur J Pain, 25, pp.1760~1769 (2021)